Related Experiment Video
Updated: Jul 9, 2026

09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
17.6K
An In Silico Modelling Approach to Predict Hemodynamic Outcomes in Diabetic and Hypertensive Kidney Disease.
Ning Wang1,2,3, Ivan Benemerito4,5, Steven P Sourbron4,6
1INSIGNEO Institute for In Silico Medicine, The University of Sheffield, Sheffield, UK. ning.wang@sheffield.ac.uk.
Annals of Biomedical Engineering
|July 5, 2024
Summary
This study introduces a computational model to identify early kidney disease biomarkers from renal blood flow. The model simulates blood flow in virtual populations, offering a non-invasive diagnostic approach for diabetic and hypertensive nephropathy.
Area of Science:
- Computational modeling
- Biomarker discovery
- Nephrology
Background:
- Early diagnosis of kidney disease is challenging, hindering timely intervention.
- Diabetes and hypertension are leading causes of kidney disease, often co-occurring.
- Distinguishing between diabetic and hypertensive kidney disease typically requires invasive biopsy.
Purpose of the Study:
- To develop a computational modeling approach to simulate renal hemodynamics in virtual populations.
- To identify potential non-invasive biomarkers for early kidney disease detection.
- To validate the model against existing in vivo data for aging, diabetic, and hypertensive populations.
Main Methods:
- Developed a computational model simulating blood velocity, flow rate, and pressure wave propagation in arterial networks.
- Validated the model using literature data on aging populations for pressure, flow rate, and waveform indices.
- Calibrated the model with in vivo data on diabetic and hypertensive nephropathy.
Main Results:
- Identified potential biomarkers from renal blood flow rate and pulsatility.
- Quantified resistive index changes in early and severe diabetic nephropathy (0.69–0.74) and hypertensive nephropathy (0.65–0.73).
- Reported mean renal blood flow rates differentiating disease stages in diabetic (317–329 ml/min) and hypertensive (388–443 ml/min) nephropathy.
Conclusions:
- The developed modeling approach shows promise for identifying novel biomarkers for early kidney disease diagnosis.
- This non-invasive method can aid in distinguishing between diabetic and hypertensive nephropathy.
- The model facilitates biomarker discovery and the design of future clinical trials for kidney disease.

